Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Apply
CD30 BiAb-AATC
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step